Posts With Tag Travere Therapeutics

Explore the latest 8-K filing from Travere Therapeutics (TVTX) detailing vital financials and updates as of February 20, 2025. Essential for stakeholders and investors.

Explore key details from Travere Therapeutics, Inc.'s 8-K SEC filing on February 11, 2025, including stock info and company registration.